After yesterday’s stellar start to the week for the junior market, Tuesday’s performance has been rather more measured with the index giving back a couple of points but the all share is still well clear of that 800 level, closing at 807.33.
- T42 IoT +47%
- Powerhouse Energy +31%
- ADVFN +17%
- ValiRx -20%
- Distil -18%
T42 IoT [LON:T42] topped the board, adding 47% on the day following a mid-session announcement that it had entered into a significant agreement with a US reseller for a deal set to be worth $7m over three years. That takes orders signed since the start of the calendar year to in excess of 100,000 units to be delivered over the next three years.
Powerhouse Energy LON:PHE was up 31% following its announcement this morning that the company had been granted a GB patent application. This is seen as another significant milestone for the company, taking year to date gains to around 250%.
ValiRx LON:VAL was down 20%, giving back some of yesterday’s exuberant gains off the back of that business update and certainly knocking the froth out of the market.
- AIM Market Roundup: Fiinu, Catenai, Frontier Developments
- AIM Market Roundup: Blue Star Capital, Trellus Health, Distil
- Small Cap Stocks: Catenai, Genip, ValiRx
Distil LON:DIS also has a rough session, off 18% but the move was inside the quoted closing spread and trading was limited. Nothing to see here although this does send the stock back to levels not seen since early December.
ADVFN LON:AFN gets the notable mention, up 17% and extending yesterday’s gains. The company this morning disclosed that a non-exec director had bought 60,000 shares in the company, accounting for a fair proportion of yesterday’s trade. Whilst this is a clear vote of confidence in the business, a lack of liquidity – NMS (Normal Market Size) is 3,000 – will exacerbate this kind of impact on the share price.
